Literature DB >> 21764620

Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes.

F-L Vélayoudom-Céphise1, L Larifla, J-P Donnet, S Maimaitiming, J Deloumeaux, A Blanchet, C Massart, N Munoz-Bellili, S Merle, R Chout, F Bonnet, L Foucan.   

Abstract

AIM: The prevalence of diabetes in the French West Indies is three times higher than in mainland France. We aimed to assess the associations between vitamin D deficiency, vitamin D receptor (VDR) gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes (T2D).
METHODS: In this cross-sectional study of 277 patients, 25-hydroxyvitamin D was measured by radioimmunoassay. FokI, BsmI, ApaI and TaqI single nucleotide polymorphisms (SNPs) of the VDR gene were genotyped. Analysis of covariance and logistic regression were performed.
RESULTS: The study included 76 patients of Indian descent and 201 patients of African descent. The prevalence of vitamin D deficiency (<20 ng/mL) was 42.6%. When patients were classified into groups with (G1) and without (G2) vitamin D deficiency, there were no significant differences in age, systolic blood pressure, low-density lipoprotein cholesterol and HbA(1c), although body mass index was significantly higher in G1. Vitamin D deficiency was significantly associated with increased diastolic blood pressure and triglyceride levels, and reduced high-density lipoprotein cholesterol (P<0.05). Prevalence of vitamin D deficiency was decreased in patients carrying the f allele of FokI (OR: 0.52; P=0.02) and the aa genotype of ApaI (OR: 0.46; P=0.05). BsmI and TaqI SNPs were not associated with vitamin D deficiency.
CONCLUSION: The rate of vitamin D deficiency was high in our T2D patients, and was associated with the VDR gene FokI and ApaI polymorphisms and cardiovascular risk profile. Measurements of vitamin D may help to detect T2D patients with cardiovascular risk, and VDR polymorphisms might explain why vitamin D deficiency is so frequently seen in some T2D patients.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764620     DOI: 10.1016/j.diabet.2011.05.005

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  17 in total

1.  Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes?

Authors:  Giovanna Muscogiuri; Vincenzo Nuzzo; Adriano Gatti; Alfonso Zuccoli; Silvia Savastano; Carolina Di Somma; Rosario Pivonello; Francesco Orio; Annamaria Colao
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

2.  Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects.

Authors:  Zhan Guo; Jianguo Wen; Quancheng Kan; Shuman Huang; Xianghua Liu; Ning Sun; Zhenzhen Li
Journal:  Tumour Biol       Date:  2013-06-27

3.  Association of Vitamin D Deficiency and Vitamin D Receptor Genetic Variants With Coronary Artery Disease in Type 2 Diabetic Saudi Patients.

Authors:  Alaa Shafie; Ahmad El Askary; Mazen Almehmadi; Hatem H Allam; Lamiaa K Elsayyad; Asmaa F Hassan; Bader B Althobaiti; Amin Nadheef; Aisha H Alharthi; Amal F Gharib
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

4.  Vitamin D Receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach.

Authors:  Tirang R Neyestani; Abolghassem Djazayery; Sakineh Shab-Bidar; Mohammad Reza Eshraghian; Ali Kalayi; Nastaran Shariátzadeh; Niloufar Khalaji; Malihe Zahedirad; A'zam Gharavi; Anahita Houshiarrad; Maryam Chamari; Sepideh Asadzadeh
Journal:  Diabetes Care       Date:  2012-11-16       Impact factor: 19.112

5.  Polymorphisms in GC and NADSYN1 Genes are associated with vitamin D status and metabolic profile in Non-diabetic adults.

Authors:  Lydia Foucan; Fritz-Line Vélayoudom-Céphise; Laurent Larifla; Christophe Armand; Jacqueline Deloumeaux; Cedric Fagour; Jean Plumasseau; Marie-Line Portlis; Longjian Liu; Fabrice Bonnet; Jacques Ducros
Journal:  BMC Endocr Disord       Date:  2013-09-29       Impact factor: 2.763

6.  T-cell cytokine gene polymorphisms and vitamin D pathway gene polymorphisms in end-stage renal disease due to type 2 diabetes mellitus nephropathy: comparisons with health status and other main causes of end-stage renal disease.

Authors:  Alicja E Grzegorzewska; Grzegorz Ostromecki; Paulina Zielińska; Adrianna Mostowska; Paweł P Jagodziński
Journal:  J Diabetes Res       Date:  2014-12-22       Impact factor: 4.011

7.  Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.

Authors:  Murielle Bochud; Michel Burnier; Idris Guessous
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-12

8.  25-OH-Vitamin D and procalcitonin levels after correction of acute hyperglycemia.

Authors:  Nalan Metin Aksu; Duygu Yazgan Aksoy; Meltem Akkaş; Hakkı Yilmaz; Canan Akman; Bülent Okan Yildiz; Mahir M Ozmen; Aydan Usman
Journal:  Med Sci Monit       Date:  2013-04-12

9.  Response to the editorial on "Defining vitamin D deficiency, using surrogate markers".

Authors:  Subhosmito Chakraborty; Mohandas K Mallath
Journal:  Indian J Endocrinol Metab       Date:  2014-03

Review 10.  Developments in renal pharmacogenomics and applications in chronic kidney disease.

Authors:  Ariadna Padullés; Inés Rama; Inés Llaudó; Núria Lloberas
Journal:  Pharmgenomics Pers Med       Date:  2014-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.